4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide

C25H29BrN4O2S — CID 6616300

IUPAC4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide
SMILESCC1CCN(CCCNC(=O)c2ccc(Cn3c(=S)[nH]c4ccc(Br)cc4c3=O)cc2)CC1
InChIInChI=1S/C25H29BrN4O2S/c1-17-9-13-29(14-10-17)12-2-11-27-23(31)19-5-3-18(4-6-19)16-30-24(32)21-15-20(26)7-8-22(21)28-25(30)33/h3-8,15,17H,2,9-14,16H2,1H3,(H,27,31)(H,28,33)
InChIKeyCTMZIBQWOSJUMY-UHFFFAOYSA-N
MW529.50 g/mol
LogP4.72
Rot. Bonds7

About 4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide

4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide (PubChem CID 6616300) has the molecular formula C25H29BrN4O2S and a molecular weight of 529.50 g/mol. Its IUPAC name is 4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide.

Molecular Properties

Compound Name4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide
PubChem CID6616300
Molecular FormulaC25H29BrN4O2S
Molecular Weight529.50 g/mol
Exact Mass528.12
IUPAC Name4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide
SMILESCC1CCN(CCCNC(=O)c2ccc(Cn3c(=S)[nH]c4ccc(Br)cc4c3=O)cc2)CC1
InChIInChI=1S/C25H29BrN4O2S/c1-17-9-13-29(14-10-17)12-2-11-27-23(31)19-5-3-18(4-6-19)16-30-24(32)21-15-20(26)7-8-22(21)28-25(30)33/h3-8,15,17H,2,9-14,16H2,1H3,(H,27,31)(H,28,33)
InChIKeyCTMZIBQWOSJUMY-UHFFFAOYSA-N
XLogP4.72
TPSA70.13 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds7
Heavy Atoms33
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500529.50
LogP ≤ 54.72
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Thiocarbonyl_group', 'substructure': 'N/A'}

Analyze 4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide?
The IUPAC name of 4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide (CID 6616300) is 4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide.
What is the SMILES notation for 4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide?
The canonical SMILES for 4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide is CC1CCN(CCCNC(=O)c2ccc(Cn3c(=S)[nH]c4ccc(Br)cc4c3=O)cc2)CC1.
What is the InChIKey of 4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide?
The InChIKey is CTMZIBQWOSJUMY-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H29BrN4O2S/c1-17-9-13-29(14-10-17)12-2-11-27-23(31)19-5-3-18(4-6-19)16-30-24(32)21-15-20(26)7-8-22(21)28-25(30)33/h3-8,15,17H,2,9-14,16H2,1H3,(H,27,31)(H,28,33).
What are the key properties of 4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide?
4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide has a molecular weight of 529.50 g/mol, XLogP of 4.72, 7 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(6-bromo-4-oxo-2-sulfanylidene-1H-quinazolin-3-yl)methyl]-N-[3-(4-methylpiperidin-1-yl)propyl]benzamide is sourced from PubChem (CID 6616300), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).